Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Frontiers in Oncology|June 16, 2025
Landscape of targets within nucleoside metabolism for the modification of immune responsesElla M Dunderdale, Evan R Abt
Biorxiv : the Preprint Server for Biology|August 30, 2023
Targeting host deoxycytidine kinase mitigates <i>Staphylococcus aureus</i> abscess formationVolker Winstel, Evan R Abt, Thuc M Le, et al.
Elife|March 21, 2024
Targeting host deoxycytidine kinase mitigates <i>Staphylococcus aureus</i> abscess formationVolker Winstel, Evan R Abt, Thuc M Le, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 2021
<sup>18</sup>F-FLT PET/CT as a Prognostic Imaging Biomarker of Disease-Specific Survival in Patients with Primary Soft-Tissue SarcomaJoseph G Crompton, Wesley R Armstrong, Mark A Eckardt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2023
MEK Inhibition Sensitizes Pancreatic Cancer to STING Agonism by Tumor Cell-intrinsic Amplification of Type I IFN SignalingRazmik Ghukasyan, Keke Liang, Kevin Chau, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 4, 2021
STING-driven interferon signaling triggers metabolic alterations in pancreas cancer cells visualized by [<sup>18</sup>F]FLT PET imagingKeke Liang, Evan R Abt, Thuc M Le, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 20, 2026
Synthetic lethality between RB-loss and E2F3 inhibition in small cell cancers targeted by pyrimidine synthesis blockadeEvan R Abt, Liang Wang, Grigor Varuzhanyan, et al.
Theranostics|January 7, 2020
Histone deacetylase inhibition is synthetically lethal with arginine deprivation in pancreatic cancers with low argininosuccinate synthetase 1 expressionStephanie S Kim, Shili Xu, Jing Cui, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 18, 2021
NAD<sup>+</sup> depletion by type I interferon signaling sensitizes pancreatic cancer cells to NAMPT inhibitionAlexandra M Moore, Lei Zhou, Jing Cui, et al.
Cell Chemical Biology|November 18, 2019
Metabolic Modifier Screen Reveals Secondary Targets of Protein Kinase Inhibitors within Nucleotide MetabolismEvan R Abt, Ethan W Rosser, Matthew A Durst, et al.
Pageof 3